Cargando…

The interdependence of antibody C and V regions on specificity and affinity: Significant implications for the engineering of therapeutic antibodies

Detalles Bibliográficos
Autor principal:	Nosanchuk, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359721/ https://www.ncbi.nlm.nih.gov/pubmed/23979029 http://dx.doi.org/10.4161/viru.26153

Ejemplares similares

Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering
por: Thakkar, Shraddha, et al.
Publicado: (2014)

Three Recombinant Engineered Antibodies against Recombinant Tags with High Affinity and Specificity
por: Zhao, Hongyu, et al.
Publicado: (2016)

Radioimmunotherapy of Fungal Diseases: The Therapeutic Potential of Cytocidal Radiation Delivered by Antibody Targeting Fungal Cell Surface Antigens
por: Nosanchuk, Joshua D., et al.
Publicado: (2012)

Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification
por: Barredo-Vacchelli, Gabriela R., et al.
Publicado: (2021)

Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor
por: Han, Chungyong, et al.
Publicado: (2020)

Engineered Ultra-High Affinity Synthetic Antibodies for SARS-CoV-2 Neutralization and Detection
por: Slezak, Tomasz, et al.
Publicado: (2021)

Generation of metastatic melanoma specific antibodies by affinity purification
por: Schütz, Birgit, et al.
Publicado: (2016)

Affinity-Based Methods for Site-Specific Conjugation of Antibodies
por: von Witting, Emma, et al.
Publicado: (2021)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

Recent Advances in Antibody Therapeutics
por: Heo, Yong-Seok
Publicado: (2022)

Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods
por: Chae, Heesu, et al.
Publicado: (2021)

Significance of antinuclear antibodies in patients with COVID-19
por: Cho, Oh-Hyun
Publicado: (2023)

Interdependence of Dosage Form Microstructure and Performance
por: Axel Zeitler, J., et al.
Publicado: (2017)

COVID-19: learning as an interdependent world
por: The Lancet
Publicado: (2021)

High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1
por: Opaliński, Łukasz, et al.
Publicado: (2018)

Mobile Affinity Selection Chromatography Analysis of Therapeutic Monoclonal Antibodies
por: Narsimhan, Meena L., et al.
Publicado: (2023)

Special Issue “Antibody Engineering for Cancer Immunotherapy”
por: Crescioli, Silvia, et al.
Publicado: (2022)

Determining the affinity of anti-SARS-CoV-2 antibody directly in biological samples and the influence of affinity on quantitative antibody assays
por: Macdonald, Patrick J., et al.
Publicado: (2022)

Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
por: Engelhart, Emily, et al.
Publicado: (2022)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

Special issue on therapeutic antibodies and biopharmaceuticals
por: Chung, Junho
Publicado: (2017)

Antibody Therapy for Histoplasmosis
por: Nosanchuk, Joshua D., et al.
Publicado: (2012)

Non-Affinity Purification of Antibodies
por: Arakawa, Tsutomu, et al.
Publicado: (2023)

Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling
por: Emmenegger, Marc, et al.
Publicado: (2023)

Improving antibody affinity through in vitro mutagenesis in complementarity determining regions
por: Ye, Wei, et al.
Publicado: (2022)

Aptamer BC 007’s Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies
por: Haberland, Annekathrin, et al.
Publicado: (2021)

Revealing the SARS-CoV-2 Spike Protein and Specific Antibody Immune Complex Formation Mechanism for Precise Evaluation of Antibody Affinity
por: Plikusiene, Ieva, et al.
Publicado: (2023)

Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration
por: Fiedler, Sebastian, et al.
Publicado: (2022)

Who Should Pay for Interdependent Risk? Policy Implications for Security Interdependence Among Airports
por: Kuper, Gabriel, et al.
Publicado: (2020)

Mutation specific antibodies: tool or dinosaur?
por: von Deimling, Andreas, et al.
Publicado: (2012)

Emergence and significance of carbohydrate-specific antibodies
por: Kappler, Katharina, et al.
Publicado: (2020)

Biosimilar, biobetter and next generation therapeutic antibodies
Publicado: (2011)

HAPTEN-SPECIFIC TOLERANCE : PREFERENTIAL DEPRESSION OF THE HIGH AFFINITY ANTIBODY RESPONSE
por: Davie, Joseph M., et al.
Publicado: (1972)

Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space
por: Makowski, Emily K., et al.
Publicado: (2022)

A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune Cells
por: Thaker, Youg R., et al.
Publicado: (2022)

Improvement of antibody affinity by introduction of basic amino acid residues into the framework region
por: Fukunaga, Atsushi, et al.
Publicado: (2018)

In vitro-engineered non-antibody protein therapeutics
por: Simeon, Rudo, et al.
Publicado: (2017)

Antibody Structure and Function: The Basis for Engineering Therapeutics
por: Chiu, Mark L., et al.
Publicado: (2019)

Demonstration of an antibody-mediated tolerance state and its effect on antibody affinity
Publicado: (1975)

Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer
por: Ko, Bong-Kook, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9a21m95uq11q7fuf4d50g4ua2t